In the latest trading session, 2.03 million Applied Therapeutics Inc (NASDAQ:APLT) shares changed hands as the company’s beta touched 1.93. With the company’s most recent per share price at $0.64 changed hands at -$0.04 or -6.30% at last look, the market valuation stands at $74.04M. APLT’s current price is a discount, trading about -1559.37% off its 52-week high of $10.62. The share price had its 52-week low at $0.65, which suggests the last value was -1.56% down since then. When we look at Applied Therapeutics Inc’s average trading volume, we note the 10-day average is 7.32 million shares, with the 3-month average coming to 6.09 million.
Analysts gave the Applied Therapeutics Inc (APLT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.17. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended APLT as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Applied Therapeutics Inc’s EPS for the current quarter is expected to be -0.19.
Applied Therapeutics Inc (NASDAQ:APLT) trade information
Instantly APLT was in red as seen in intraday trades today. With action -32.57%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -25.68%, with the 5-day performance at -32.57% in the red. However, in the 30-day time frame, Applied Therapeutics Inc (NASDAQ:APLT) is -47.41% down. Looking at the short shares, we see there were 18.15 million shares sold at short interest cover period of 1.85 days.
The consensus price target for the stock as assigned by Wall Street analysts is 4.5, meaning bulls need an upside of 85.78% from its recent market value. According to analyst projections, APLT’s forecast low is 4 with 5 as the target high. To hit the forecast high, the stock’s price needs a -681.25% plunge from its current level, while the stock would need to soar -525.0% for it to hit the projected low.
Applied Therapeutics Inc (APLT) estimates and forecasts
Data shows that the Applied Therapeutics Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -88.54% over the past 6 months, a 11.27% in annual growth rate that is considerably lower than the industry average of 16.40%. Year-over-year growth is forecast to reach -94.66% down from the last financial year.
Consensus estimates given by 3 financial analysts project the company’s revenue in the current quarter to hit an average of 100k. 3 analysts are of the opinion that Applied Therapeutics Inc’s revenue for the current quarter will be 12.32M. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 6,382.46%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -8.72%. The 2025 estimates are for Applied Therapeutics Inc earnings to increase by 1.41%.
APLT Dividends
Applied Therapeutics Inc is expected to release its next quarterly earnings report in February.
Applied Therapeutics Inc (NASDAQ:APLT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 5.80% of Applied Therapeutics Inc shares while 106.63% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 113.19%. There are 106.63% institutions holding the Applied Therapeutics Inc stock share, with FRANKLIN RESOURCES INC the top institutional holder. As of 2024-06-30, the company held 8.1496% of the shares, roughly 10.21 million APLT shares worth $47.69 million.
VR ADVISER, LLC holds the second largest percentage of outstanding shares, with 7.6149% or 9.54 million shares worth $44.57 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Simplify Exchange Traded Fds-Simplify Propel Opportunities ETF. With 3.15 shares estimated at $1.96 million under it, the former controlled 2.71% of total outstanding shares. On the other hand, Simplify Exchange Traded Fds-Simplify Propel Opportunities ETF held about 2.42% of the shares, roughly 2.82 shares worth around $1.75 million.
